Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in pediatric limb lengthening and deformity correction
NCT00412035Phase 3Completed
- Sponsor
- Shriners Children's
- Start
- Jan 2007
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in limb length discrepancy (LLD) and Congenital Lower Extremity Deformity, sponsored by Shriners Children's. Primary endpoints: Average pain scores and Total amount of narcotic used. Started Jan 2007; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
limb length discrepancy (LLD)Congenital Lower Extremity Deformity
Beyond the preview
Go deeper on NCT00412035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412035.